Literature DB >> 25516783

Inhibition of O-GlcNAcase (OGA): A Potential Therapeutic Target to Treat Alzheimer's Disease.

Ahmed F Abdel-Magid1.   

Abstract

Entities:  

Year:  2014        PMID： 25516783      PMCID： PMC4265821          DOI： 10.1021/ml500450c

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN： 1948-5875            Impact factor:   4.345


× No keyword cloud information.
  3 in total

1.  Neurodegeneration: Recall sugars, forget Alzheimer's.

Authors:  Tony Lefebvre
Journal:  Nat Chem Biol       Date:  2012-03-16       Impact factor: 15.040

Review 2.  O-GlcNAc modification and the tauopathies: insights from chemical biology.

Authors:  Scott A Yuzwa; David J Vocadlo
Journal:  Curr Alzheimer Res       Date:  2009-10       Impact factor: 3.498

Review 3.  Increasing O-GlcNAc levels: An overview of small-molecule inhibitors of O-GlcNAcase.

Authors:  Matthew S Macauley; David J Vocadlo
Journal:  Biochim Biophys Acta       Date:  2009-08-04
  3 in total
  1 in total

1.  Oxidized CaMKII and O-GlcNAcylation cause increased atrial fibrillation in diabetic mice by distinct mechanisms.

Authors:  Olurotimi O Mesubi; Adam G Rokita; Neha Abrol; Yuejin Wu; Biyi Chen; Qinchuan Wang; Jonathan M Granger; Anthony Tucker-Bartley; Elizabeth D Luczak; Kevin R Murphy; Priya Umapathi; Partha S Banerjee; Tatiana N Boronina; Robert N Cole; Lars S Maier; Xander H Wehrens; Joel L Pomerantz; Long-Sheng Song; Rexford S Ahima; Gerald W Hart; Natasha E Zachara; Mark E Anderson
Journal:  J Clin Invest       Date:  2021-01-19       Impact factor: 14.808
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.